Found: 3
Select item for more details and to access through your institution.
Bevacizumab at first recurrence after standard radio-chemotherapy is associated with improved overall survival in glioblastoma patients with large tumor burden.
- Published in:
- Neuro-Oncology Practice, 2019, v. 6, n. 2, p. 103, doi. 10.1093/nop/npy021
- By:
- Publication type:
- Article
Retrospective examination of pseudoprogression in IDH mutant gliomas.
- Published in:
- Neuro-Oncology Advances, 2023, v. 5, n. 1, p. 1, doi. 10.1093/noajnl/vdad028
- By:
- Publication type:
- Article
Selective DRD2 antagonist and ClpP agonist ONC201 in a recurrent non-midline H3 K27M-mutant glioma cohort.
- Published in:
- Neuro-Oncology, 2024, v. 26, p. S165, doi. 10.1093/neuonc/noae021
- By:
- Publication type:
- Article